Ms. Sara Kaveh, Tehran University of Medical Sciences, Iran
Ms. Sara Kaveh is a dedicated researcher and academic affiliated with Tehran University of Medical Sciences, Iran. Her work focuses on advancing medical research and education within the field of health sciences. She has contributed to various projects aimed at improving healthcare outcomes and is recognized for her commitment to scientific excellence and innovation.
Ms. Sara Kaveh is a PhD candidate in Health Economics at Tehran University of Medical Sciences, where her dissertation explores regionalization models for pancreaticoduodenectomy in Iran, focusing on outcomes and costs. She earned her M.Sc. in Health Technology Assessment from Iran University of Medical Sciences, with a dissertation comparing bevacizumab and its combination with erlotinib for metastatic colorectal cancer. Earlier, she completed an M.Sc. in Health Information Technology at Kerman University of Medical Sciences, investigating the use of the Internet for health information among academic professionals. Her work integrates health economics and technology assessment to enhance healthcare delivery and policy.
Ms. Sara Kaveh is currently a Research Assistant at Shiraz University of Medical Sciences, a role she began in November 2023, building on her previous tenure at the same institution from August 2019 to August 2021. From June 2017 to August 2019, she worked as an independent researcher, leading multidisciplinary teams and publishing extensively in high-impact journals. Her research spans health economics and technology assessment, contributing significantly to the academic and practical understanding of healthcare improvements.
Ms. Sara Kaveh achieved notable academic distinctions, securing 4th place in the highly competitive Ph.D. entrance exam in Iran and 6th place in the M.Sc. entrance exam. These rankings underscore her exceptional academic capabilities and commitment to excellence in her field of health economics and technology assessment.
Top Notable Publications:
Cost-effectiveness of Evolocumab in Cardiovascular Disease: A Systematic Review
Journal: Current Therapeutic Research
Date: September 2024
DOI: 10.1016/j.curtheres.2024.100758
Telehealth impact on biomedical, psychosocial, and behavioural outcomes in patients with diabetes older than 50 years: A systematic synthesis without meta-analysis
Journal: Journal of Telemedicine and Telecare
Date: February 2024
DOI: 10.1177/1357633X211052222
Clinical Characteristics, Laboratory Features, and Outcomes of 151 Pediatric Patients with COVID-19 and MIS-C: A Single-center Study in the Northwest of Iran
Journal: Archives of Pediatric Infectious Diseases
Date: May 7, 2023
DOI: 10.5812/pedinfect-132819
Mobile Health-Based Interventions in Self-care and Treatment Adherence in Older People: A Review Study
Journal: International Journal of Aging
Date: April 27, 2023
DOI: 10.34172/ija.2023.e6
Prevention of anthracycline-induced cardiotoxicity: a systematic review and network meta-analysis
Journal: International Journal of Clinical Pharmacy
Date: 2021
DOI: 10.1007/S11096-020-01146-6
WOSUID: WOS:000568149400001
Comparing cardiac troponin levels using sevoflurane and isoflurane in patients undergoing cardiac surgery: a systematic review and meta-analysis
Journal: Journal of Cardiovascular and Thoracic Research
Date: February 12, 2020
DOI: 10.34172/jcvtr.2020.01
Efficacy and safety of Romosozumab in treatment for low bone mineral density: a systematic review and meta-analysis
Journal: Clinical Rheumatology
Date: 2020
DOI: 10.1007/S10067-020-04948-1
WOSUID: WOS:000531129700001
Bevacizumab and erlotinib versus bevacizumab for colorectal cancer treatment: systematic review and meta-analysis
Journal: International Journal of Clinical Pharmacy
Date: 2019
DOI: 10.1007/S11096-018-0754-1
WOSUID: WOS:000458652000008
Comparative efficacy of ivabradine versus beta-blockers in patients with mitral stenosis in sinus rhythm: systematic review and meta-analysis
Journal: International Journal of Clinical Pharmacy
Date: 2019
DOI: 10.1007/S11096-018-00778-Z
WOSUID: WOS:000458652000007
Health technology assessment of Bevacizumab compare with combination of Bevacizumab with Erlotinib for treatment of patients with metastatic colorectal cancer
DOI: 10.22037/IPA.V1I1.20015
The Efficacy of Ivabradine versus Beta Blockers in Comparison of Atenolol and Metoprolol in Patients with Mitral Stenosis in Sinus Rhythm: A Systematic Review and Meta-Analysis
DOI: 10.22037/IPA.V1I1.20006